Levetiracetam Zentiva

Levetiracetam, the active ingredient in Levetiracetam Zentiva, is an antiepileptic presented as an oral tablet for oral use. It reduces neuronal excitability and is indicated for the control of partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients diagnosed with epilepsy.

GNH USA supplies Levetiracetam Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance.

Levetiracetam is an antiepileptic drug that acts on seizure activity across several epilepsy syndromes.

Partial‑onset seizures: helps achieve reduction in seizure frequency and improves overall seizure control. Generalized tonic‑clonic seizures: contributes to lowering the number of convulsive episodes. Myoclonic seizures: assists in decreasing the occurrence of sudden muscle jerks.

Levetiracetam may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness - Somnolence - Fatigue - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe allergic reactions such as Stevens‑Johnson syndrome - Mood alterations including depression or suicidal thoughts - Severe skin rash - Hematologic abnormalities (e.g., leukopenia) - Multi‑organ hypersensitivity reactions

Levetiracetam requires careful consideration of patient‑specific factors and safety measures.

Renal function: dose may need adjustment in impaired renal function. Psychiatric symptoms: monitor for mood changes, depression, or aggression. Driving: exercise caution if experiencing dizziness or drowsiness. Concomitant CNS depressants: may enhance sedation. Pregnancy and lactation: risk unknown; use only if benefit outweighs potential risk. Store at below 25°C: keep in the original packaging, protect from moisture.

Levetiracetam can interact with other medicines, influencing its effectiveness or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenytoin: may decrease levetiracetam exposure. - Phenobarbital: may lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: additive central nervous system depression. - Other antiepileptics (e.g., valproate, lamotrigine): monitor seizure control. - Renal excretion inhibitors (e.g., probenecid): may increase levetiracetam levels.